Dr. David Valle Speaks About Evolutionary Medicine

In this video, Dr. David Valle, Professor and Director of the Institute of Genetic Medicine at Johns Hopkins University School of Medicine, discusses the advancement of evolutionary medicine and also speaks about the Johns Hopkins Individualized Medicine Program.

Related Videos

Related Content

Advertisement

October 3rd 2024

What the Approval of Isatuximab Plus VRd Adds to Multiple Myeloma Care

Hayden E. Klein Maggie L. Shaw

Surbhi Sidana, MD, MBBS, shares how the addition of an anti-CD38 antibody to the VRd regimen significantly improves progression-free survival for patients with transplant-ineligible multiple myeloma.

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 2nd 2024

From Criminalization to Compassion: The Evolution of HIV Laws

Maggie L. Shaw

The 25th International AIDS Conference took place July 22-26 in Munich, Germany, and one of the sessions delved into the potential impact of civil society laws on the 95-95-95 targets as laid out in the UNAIDS Global AIDS Strategy for 2021 to 2026.

September 27th 2024

Frameworks for Advancing Health Equity: Community Wellness Centers

Giuliana Grossi

Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.

September 30th 2024

Amivantamab Presents an Exciting Treatment Opportunity in NSCLC

Maggie L. Shaw

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals from the FDA for use in non–small cell lung cancer (NSCLC).

September 29th 2024

Efficacy of Finerenone Around Recent Worsening Heart Failure

Laura Joszt, MA

Finerenone is at least as effective in patients who are in the hospital or were recently hospitalized for heart failure as those with stable condition, said Akshay Desai, MD, of Brigham & Women’s Hospital.

Related Content

Advertisement

October 3rd 2024

What the Approval of Isatuximab Plus VRd Adds to Multiple Myeloma Care

Hayden E. Klein Maggie L. Shaw

Surbhi Sidana, MD, MBBS, shares how the addition of an anti-CD38 antibody to the VRd regimen significantly improves progression-free survival for patients with transplant-ineligible multiple myeloma.

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 2nd 2024

From Criminalization to Compassion: The Evolution of HIV Laws

Maggie L. Shaw

The 25th International AIDS Conference took place July 22-26 in Munich, Germany, and one of the sessions delved into the potential impact of civil society laws on the 95-95-95 targets as laid out in the UNAIDS Global AIDS Strategy for 2021 to 2026.

September 27th 2024

Frameworks for Advancing Health Equity: Community Wellness Centers

Giuliana Grossi

Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.

September 30th 2024

Amivantamab Presents an Exciting Treatment Opportunity in NSCLC

Maggie L. Shaw

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals from the FDA for use in non–small cell lung cancer (NSCLC).

September 29th 2024

Efficacy of Finerenone Around Recent Worsening Heart Failure

Laura Joszt, MA

Finerenone is at least as effective in patients who are in the hospital or were recently hospitalized for heart failure as those with stable condition, said Akshay Desai, MD, of Brigham & Women’s Hospital.